The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Center: A Retrospective Chart Review

被引:36
作者
Kasymjanova, Goulnar [1 ]
Anwar, Aksa [2 ]
Cohen, Victor [3 ]
Sultanem, Khalil [4 ]
Pepe, Carmela [1 ]
Sakr, Lama [1 ]
Friedmann, Jennifer [3 ]
Agulnik, Jason S. [1 ]
机构
[1] McGill Univ, Jewish Gen Hosp, Peter Brojde Lung Canc Ctr, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada
[3] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Med Oncol, Montreal, PQ H3T 1E2, Canada
[4] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Radiat Oncol, Montreal, PQ H3T 1E2, Canada
关键词
lung cancer; COVID-19; diagnosis and treatment pattern; CARE; PROGNOSIS; SURGERY; TIMES;
D O I
10.3390/curroncol28060360
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The large burden of COVID-19 on health care systems worldwide has raised concerns among medical oncologists about the impact of COVID-19 on the diagnosis and treatment of lung cancer patients. In this retrospective cohort study, we investigated the impact of COVID-19 on lung cancer diagnosis and treatment before and during the COVID-19 era. New lung cancer diagnoses decreased by 34.7% during the pandemic with slightly more advanced stages of disease, there was a significant increase in the utilization of radiosurgery as the first definitive treatment, and a decrease in both systemic treatment as well as surgery compared to the pre-COVID-19 era. There was no significant delay in starting chemotherapy and radiation treatment during the pandemic compared to pre-COVID-19 time. However, we observed a delay to lung cancer surgery during the pandemic time. COVID-19 seems to have had a major impact at our lung cancer center on the diagnoses and treatment patterns of lung cancer patients. Many oncologists fear that they will see an increase in newly diagnosed lung cancer patients in the coming year. This study is still ongoing and further data will be collected and analyzed to better understand the total impact of the COVID-19 pandemic on our lung cancer patient population.
引用
收藏
页码:4247 / 4255
页数:9
相关论文
共 26 条
  • [1] [Anonymous], 1998, Thorax, V53 Suppl 1, pS1
  • [2] Antonoff M, 2020, ANN THORAC SURG, V110, P692, DOI [10.1016/j.athoracsur.2020.03.005, 10.1016/j.jtcvs.2020.03.061]
  • [3] Non-small cell lung cancer stage migration as a function of wait times from diagnostic imaging: A pooled analysis from five international centres[J]. Bissonnette, Jean-Pierre;Sun, Alexander;Grills, Inga S.;Almahariq, Muayad F.;Geiger, Geoffrey;Vogel, Wouter;Sonke, Jan-Jakob;Everitt, Sarah;Mac Manus, Michael. LUNG CANCER, 2021
  • [4] Consensus statement: summary of the Quebec Lung Cancer Network recommendations for prioritizing patients with thoracic cancers in the context of the COVID-19 pandemic[J]. Blais, N.;Bouchard, M.;Chinas, M.;Lizotte, H.;Morneau, M.;Spicer, J.;Martel, S. CURRENT ONCOLOGY, 2020(03)
  • [5] The impact of coronavirus disease 2019 on the practice of thoracic oncology surgery: a survey of members of the European Society of Thoracic Surgeons (ESTS)[J]. Depypere, Lieven P.;Daddi, Niccolo;Gooseman, Michael R.;Batirel, Hasan F.;Brunelli, Alessandro. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2020(04)
  • [6] Can we assess Cancer Waiting Time targets with cancer survival? A population-based study of individually linked data from the National Cancer Waiting Times monitoring dataset in England, 2009-2013[J]. Di Girolamo, Chiara;Walters, Sarah;Gildea, Carolynn;Majano, Sara Benitez;Rachet, Bernard;Morris, Melanie. PLOS ONE, 2018(08)
  • [7] Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic[J]. Dingemans, Anne-Marie C.;Soo, Ross A.;Jazieh, Abdul Rahman;Rice, Shawn J.;Kim, Young Tae;Teo, Lynette L. S.;Warren, Graham W.;Xiao, Shu-Yuan;Smit, Egbert F.;Aerts, Joachim G.;Yoon, Soon Ho;Veronesi, Giulia;De Cobelli, Francesco;Ramalingam, Suresh S.;Garassino, Marina C.;Wynes, Murry W.;Behera, Madhusmita;Haanen, John;Lu, Shun;Peters, Solange;Ahn, Myung-Ju;Scagliotti, Giorgio V.;Adjei, Alex A.;Belani, Chandra P. JOURNAL OF THORACIC ONCOLOGY, 2020(07)
  • [8] Impact of COVID-19 pandemic on lung cancer treatment scheduling[J]. Fujita, Kohei;Ito, Takanori;Saito, Zentaro;Kanai, Osamu;Nakatani, Koichi;Mio, Tadashi. THORACIC CANCER, 2020(10)
  • [9] COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study[J]. Garassino, Marina Chiara;Whisenant, Jennifer G.;Huang, Li-Ching;Trama, Annalisa;Torri, Valter;Agustoni, Francesco;Baena, Javier;Banna, Giuseppe;Berardi, Rossana;Bettini, Anna Cecilia;Bria, Emilio;Brighenti, Matteo;Cadranel, Jacques;De Toma, Alessandro;Chini, Claudio;Cortellini, Alessio;Felip, Enriqueta;Finocchiaro, Giovanna;Garrido, Pilar;Genova, Carlo;Giusti, Raffaele;Gregorc, Vanesa;Grossi, Francesco;Grosso, Federica;Intagliata, Salvatore;La Verde, Nicla;Liu, Stephen, V;Mazieres, Julien;Mercadante, Edoardo;Michielin, Olivier;Minuti, Gabriele;Moro-Sibilot, Denis;Pasello, Giulia;Passaro, Antonio;Scotti, Vieri;Solli, Piergiorgio;Stroppa, Elisa;Tiseo, Marcello;Viscardi, Giuseppe;Voltolini, Luca;Wu, Yi-Long;Zai, Silvia;Pancaldi, Vera;Dingemans, Anne-Marie;Van Meerbeeck, Jan;Barlesi, Fabrice;Wakelee, Heather;Peters, Solange;Horn, Leora. LANCET ONCOLOGY, 2020(07)
  • [10] Thoracic Surgeon Impressions of the Impact of the COVID-19 Pandemic on Lung Cancer Care-Lessons from the First Wave in Canada[J]. Hilzenrat, Roy A.;Deen, Shaun A.;Yee, John;Grant, Kyle A.;Ashrafi, Ahmad S.;Coughlin, Shaun;McGuire, Anna L. CURRENT ONCOLOGY, 2021(01)